159 related articles for article (PubMed ID: 27692836)
1. Predictive models and risk of biopsy progression in active surveillance patients.
Iremashvili V; Manoharan M; Kava BR; Parekh DJ; Punnen S
Urol Oncol; 2017 Feb; 35(2):37.e1-37.e8. PubMed ID: 27692836
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
[TBL] [Abstract][Full Text] [Related]
3. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
4. Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression.
Iremashvili V; Burdick-Will J; Soloway MS
BJU Int; 2013 Jul; 112(1):39-44. PubMed ID: 23551868
[TBL] [Abstract][Full Text] [Related]
5. Comparative validation of nomograms predicting clinically insignificant prostate cancer.
Iremashvili V; Soloway MS; Pelaez L; Rosenberg DL; Manoharan M
Urology; 2013 Jun; 81(6):1202-8. PubMed ID: 23561706
[TBL] [Abstract][Full Text] [Related]
6. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
Wang SY; Cowan JE; Cary KC; Chan JM; Carroll PR; Cooperberg MR
BJU Int; 2014 Dec; 114(6b):E18-E24. PubMed ID: 24712895
[TBL] [Abstract][Full Text] [Related]
7. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
Eskicorapci SY; Türkeri L; Karabulut E; Cal C; Akpinar H; Baltaci S; Baykal K; ; Kattan MW; Ozen H
Urology; 2009 Dec; 74(6):1289-95. PubMed ID: 19589584
[TBL] [Abstract][Full Text] [Related]
8. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Huland H; Scardino PT; Kattan MW
Urol Oncol; 2002; 7(4):141-6. PubMed ID: 12474529
[TBL] [Abstract][Full Text] [Related]
9. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
[TBL] [Abstract][Full Text] [Related]
10. External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.
Tanaka A; Ohori M; Paul L; Yu C; Kattan MW; Ohno Y; Tachibana M
Jpn J Clin Oncol; 2013 Dec; 43(12):1255-60. PubMed ID: 24146147
[TBL] [Abstract][Full Text] [Related]
11. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Makarov DV; Trock BJ; Humphreys EB; Mangold LA; Walsh PC; Epstein JI; Partin AW
Urology; 2007 Jun; 69(6):1095-101. PubMed ID: 17572194
[TBL] [Abstract][Full Text] [Related]
12. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
13. Can nomograms improve our ability to select candidates for active surveillance for prostate cancer?
Iremashvili V; Manoharan M; Parekh DJ; Punnen S
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):385-389. PubMed ID: 27431497
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting prostatic biopsy Gleason sum under grading.
Stackhouse DA; Sun L; Schroeck FR; Jayachandran J; Caire AA; Acholo CO; Robertson CN; Albala DM; Polascik TJ; Donatucci CF; Maloney KE; Moul JW
J Urol; 2009 Jul; 182(1):118-22; discussion 123-4. PubMed ID: 19447436
[TBL] [Abstract][Full Text] [Related]
15. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
16. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
Jansen BHE; Nieuwenhuijzen JA; Oprea-Lager DE; Yska MJ; Lont AP; van Moorselaar RJA; Vis AN
Urol Oncol; 2019 Mar; 37(3):181.e1-181.e6. PubMed ID: 30558983
[TBL] [Abstract][Full Text] [Related]
17. Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer.
Borque Á; Rubio-Briones J; Esteban LM; Sanz G; Domínguez-Escrig J; Ramírez-Backhaus M; Calatrava A; Solsona E
BJU Int; 2014 Jun; 113(6):878-86. PubMed ID: 24529282
[TBL] [Abstract][Full Text] [Related]
18. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
19. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Stephenson AJ; Scardino PT; Eastham JA; Bianco FJ; Dotan ZA; Fearn PA; Kattan MW
J Natl Cancer Inst; 2006 May; 98(10):715-7. PubMed ID: 16705126
[TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
